20 April 2007
Microgen plc (the "Company")
Notifiable Interests
The Company received notice from Aberforth Partners LLP dated 18 April 2007 in
compliance with the Disclosure and Transparency Rules that following an
acquisition Aberforth Partners LLP is interested in a total of 19,091,277
Ordinary Shares in the Company representing 18.60% of the Issued share capital
of the Company.
The notification from Aberforth Partners states that the registered holders of
shares to which it can exercise voting rights are as follows:
Number of
Shares
Aberforth Smaller Companies Trust plc 7,246,426
(Nortrust Nominees Ltd A/c Aberfrth)
Aberforth UK Small Companies Fund 6,763,451
(Nortrust Nominees Ltd A/c Aberfrth)
Aberforth Geared Capital & Income Trust plc 1,206,500
(Nortrust Nominees Ltd A/c Aberfrth)
The Church Commissioners for England 1,216,800
(The Church Commissioners for England (Chase GIS) Nominees Ltd)
Total 16,433,177
The total number of voting rights in Microgen plc is 102,651,776.
If you require further information please contact:
G.E. Liddle, Company Secretary
Tel: 01252 772 313
www.microgen.co.uk
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.